Physician profile
Seth H Evans
NPI 1083825467
$1,045.42
in general payments reported to CMS, 2019-2025
11 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $127 · 2022: $139 · 2023: $413 · 2024: $146 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $676.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $265.32 | 2019-2023 | Acclarent Aera, Trudi Nav Cable |
| Glaxosmithkline, LLC. | $139.20 | 2024-2025 | Nucala |
| Aerin Medical INC. | $122.09 | 2022 | |
| Genzyme Corporation | $121.84 | 2023 | |
| Ethicon US, LLC | $115.55 | 2020 | |
| Nuvasive, INC. | $112.61 | 2023 | Xlif |
| Integra Lifesciences Corporation | $46.19 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Stryker Corporation | $44.03 | 2019 | |
| Inspire Medical Systems, INC. | $29.95 | 2024 | Inspire |
| Ars Pharmaceuticals Operations, INC. | $27.47 | 2025 | Neffy |
| Medtronic, INC. | $21.17 | 2025 | Propel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.